Doctor profile · Federal record
Dr. Madeline Abrams, PA-C
Physician Assistant · Crest Hill, IL
- NPI 1073865697
- Accepts Medicare
- MIPS 83.3 / 100 · 2023
- 14 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
Operates at 3 locations .
- Primary practice
-
2051 Plainfield RD
Crest Hill, IL 604031865
(815) 741-4343
fax (815) 741-8660 - Additional location
-
1520 Bond St
Naperville, IL 605632358
(630) 357-7536
fax (630) 904-0413 - Additional location
-
507 W Kendall Dr Ste 2
Yorkville, IL 605602041
(630) 357-7536
fax (630) 904-0413 - Mailing address
-
801 York St
Manitowoc, WI 542204630
Credentials & registration
- NPI registered
- October 2012 — 14 yrs on file
- Profile last updated
- August 21, 2025
- Year of graduation
- 2012 — 14 yrs since
- Specialty taxonomy
- 363A00000X — NUCC code
- State license (1)
- Illinois #085.004410
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1073865697. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,410
Distinct HCPCS
10
Medicare allowed
$67,265
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 403 | 81 | $6 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 272 | 239 | $79 | |
17000 |
Destruction of precancer skin growth, 1 growth | 142 | 121 | $49 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 129 | 37 | $1 | |
17110 |
Destruction of skin growth, 1-14 growths | 121 | 106 | $101 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 87 | 77 | $50 | |
11102 |
Biopsy of related skin growth, first growth | 79 | 74 | $84 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 78 | 78 | $100 | |
11900 |
Injection into skin growth, 1-7 growths | 34 | 20 | $50 | |
99202 |
New patient office or other outpatient visit, 15-29 minutes | 32 | 32 | $64 |
In context: peer comparison
Among 2 peers in Crest Hill Physician Assistant, average services per provider: 125. This provider delivers 11× the peer median.Open Payments
Industry payments received
All-time total
$950
Transactions
33
Manufacturers
9
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbvie INC. | 18 | $489.59 | |
| Lilly USA, LLC | 2 | $102.21 | |
| Sanofi-Aventis U.S. LLC | 1 | $99.99 | |
| Novartis Pharmaceuticals Corporation | 4 | $81.91 | |
| Dermavant Sciences, INC. | 3 | $60.56 | |
| Pfizer INC. | 2 | $35.78 | |
| Genzyme Corporation | 1 | $30.85 | |
| Regeneron Healthcare Solutions, INC. | 1 | $28.76 | |
| Galderma Laboratories, L.P. | 1 | $20.03 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
607
Patients
322
Total drug cost
$135,739
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Clobetasol Propionate | Generic | 134 | 63 | $7,029 |
| Triamcinolone Acetonide | Generic | 125 | 83 | $1,929 |
| Hydrocortisone | Generic | 75 | 53 | $665 |
| Ketoconazole | Generic | 71 | 40 | $1,409 |
| Nystatin | Generic | 30 | 17 | $466 |
| Cephalexin | Generic | 25 | 14 | $918 |
| Fluocinonide | Generic | 21 | 17 | $1,216 |
| Desonide | Generic | 19 | 0 | $879 |
| Dupixent Pen (Dupilumab) | Brand | 18 | 0 | $68,356 |
| Doxycycline Hyclate | Generic | 17 | 12 | $438 |
Frequently asked questions
What is Dr. Madeline Abrams's medical specialty?
Dr. Madeline Abrams practices Physician Assistant in Crest Hill, IL.
Where does Dr. Madeline Abrams practice?
Dr. Madeline Abrams practices at 2051 Plainfield RD, Crest Hill, IL 604031865. Office phone: 8157414343.
What is Dr. Madeline Abrams's NPI?
Dr. Madeline Abrams's National Provider Identifier (NPI) is 1073865697, issued by NPPES.
Does Dr. Madeline Abrams accept Medicare assignment?
Yes. Dr. Madeline Abrams accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Madeline Abrams commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.